An observational study in Evidence of Liver Transplantation, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2015-02-18.
Sponsored by Chang Gung Memorial Hospital · Observational
Conventionally, the outcome of liver transplantation is usually reported in terms of graft and patient survival, medical and surgical complications, but lack of health-related quality of life (HRQOL) that might be associated with immunosuppression complications (e.g., diabetes, hypertension, dyslipidemia, obesity, metabolic syndrome, cardiovascular disease, renal dysfunction, osteoporosis, and de novo malignancy), disease recurrence, and rejections after transplantation.
Specific aims are proposed to achieve in this study:
Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Study subjects: Patients who had liver transplantation in Kaohsiung Chang Gung Memorial Hospital
Aim 1:
Inclusion Criteria:
Aim 2:
Inclusion Criteria:
Exclusion Criteria:
adult liver transplantation recipients (\>=20 years at the date of surgery)
incidence of graft and patient mortality, treatment-related complications
Patient will be followed from the date of liver transplantation to the occurence of outcome event for 5 years
Time frame: 5 years
health-related quality of life
health-related quality of life will be measured by EQ-5D-5L and 15D
Time frame: 5 years
quality-adjusted life expectancy (QALE), loss-of-QALE
QALE:quality-adjusted weight for each health status (measured by EQ-5D)will be multiplied by the survival time and then summed to calculate the number of QALE. Loss-of QALE: the life time expectancy (survival function) for thes study cohort will be compared with Taiwan general population of subjects who are age- and gender-matched with study subjects.
Time frame: 5 years
This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital